Clinical Trial Update: T-cell Receptor α/β Depleted Donor Lymphocyte Infusion [Phase 1]

View source ↗

Summary

Phase 1 trial of T-cell receptor α/β-depleted donor lymphocyte infusion was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Plasmacytoma

Drugs mentioned

• T-cell receptor α/β-depleted donor lymphocyte infusion

Snippet

Sponsor: Guenther Koehne | Conditions: Lymphoid Leukemia, Acute, Myeloid Malignancy | Phase 1 | Status: TERMINATED | Results posted: 2024-12-10